94 related articles for article (PubMed ID: 8112036)
21. Agar dilution method for susceptibility testing of Neisseria gonorrhoeae.
de Castillo MC; de Saab OA; de Fernandez NP; de Nader OM; de Ruiz Holgado AP
Mem Inst Oswaldo Cruz; 1996; 91(6):789-93. PubMed ID: 9283668
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Durban, South Africa.
Coovadia YM; Kharsany A; Ramsaroop U
Br J Vener Dis; 1984 Oct; 60(5):306-8. PubMed ID: 6091842
[TBL] [Abstract][Full Text] [Related]
23. [Drug susceptibility of clinically isolated strains of Neisseria gonorrhoeae].
Murakami H; Matsumoto T; Suzuki K; Kashitani F; Furuya N; Tateda K; Yamaguchi K
Kansenshogaku Zasshi; 2001 Jul; 75(7):551-6. PubMed ID: 11521277
[TBL] [Abstract][Full Text] [Related]
24. In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.
Jones RN; Barry AL; Thornsberry C; Wilson HW
Antimicrob Agents Chemother; 1981 Dec; 20(6):760-8. PubMed ID: 6275785
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Thabaut A; Durosoir JL; Saliou P
Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
[TBL] [Abstract][Full Text] [Related]
26. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Jones RN; Barry AL; Thornsberry C
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
[TBL] [Abstract][Full Text] [Related]
27. Survey on antibiotic sensitivity of Neisseria gonorrhoeae strains isolated in China, 1987-1992.
Ye SZ
Sex Transm Dis; 1994; 21(4):237-40. PubMed ID: 7974078
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolone-resistant strains.
Biedenbach DJ; Beach ML; Jones RN
Diagn Microbiol Infect Dis; 1998 Dec; 32(4):307-11. PubMed ID: 9934548
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial agent resistance in Neisseria gonorrhoeae in St. Paul Minnesota.
Lally RT; Woolfrey BF; Gresser-Burns ME; Henry K
Diagn Microbiol Infect Dis; 1988 May; 10(1):49-55. PubMed ID: 2971501
[TBL] [Abstract][Full Text] [Related]
30. Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G.
Korting HC; Behrendt H; Roth KH; Neubert U
Chemotherapy; 1984; 30(6):366-72. PubMed ID: 6097409
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic susceptibility testing of Neisseria gonorrhoeae by disk-agar diffusion.
Riou JY; Guibourdenche M; Courvalin P
Ann Microbiol (Paris); 1981; 132B(1):23-39. PubMed ID: 6795982
[TBL] [Abstract][Full Text] [Related]
32. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
[TBL] [Abstract][Full Text] [Related]
33. Tendency toward increase in the frequency of isolation of beta-lactamase-nonproducing Neisseria gonorrhoeae exhibiting penicillin resistance, and recent emergence of multidrug-resistant isolates in Japan.
Kobayashi I; Kanayama A; Saika T; Nishida M; Nakayama H; Tanaka M; Naito S
J Infect Chemother; 2003 Jun; 9(2):126-30. PubMed ID: 12825110
[TBL] [Abstract][Full Text] [Related]
34. Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India.
Sethi S; Sharma D; Mehta SD; Singh B; Smriti M; Kumar B; Sharma M
Indian J Med Res; 2006 May; 123(5):707-10. PubMed ID: 16873916
[TBL] [Abstract][Full Text] [Related]
35. Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.
Fuchs PC; Barry AL; Baker C; Murray PR; Washington JA
J Clin Microbiol; 1991 Oct; 29(10):2111-4. PubMed ID: 1939563
[TBL] [Abstract][Full Text] [Related]
36. In-vitro activity of 21 antimicrobial agents against Neisseria gonorrhoeae in Brussels.
Gordts B; Vanhoof R; Hubrechts JM; Dierickx R; Coignau H; Butzler JP
Br J Vener Dis; 1982 Feb; 58(1):23-8. PubMed ID: 6799143
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of Neisseria gonorrhoeae to cefotaxime and ceftizoxime.
Sng EH; Rajan VS; Pang R; Yeo KL
Br J Vener Dis; 1981 Jun; 57(3):162-4. PubMed ID: 6263403
[TBL] [Abstract][Full Text] [Related]
38. Cefodizime, an aminothiazolylcephalosporin. I. In vitro activity.
Limbert M; Klesel N; Seeger K; Seibert G; Winkler I; Schrinner E
J Antibiot (Tokyo); 1984 Aug; 37(8):892-900. PubMed ID: 6090373
[TBL] [Abstract][Full Text] [Related]
39. Single dose of cefodizime completely eradicated multidrug-resistant strain of Neisseria gonorrhoeae in urethritis and uterine cervicitis.
Matsumoto T; Muratani T; Takahashi K; Ando Y; Sato Y; Kurashima M; Yokoo D; Ikuyama T; Shimokawa H; Yanai S
J Infect Chemother; 2006 Apr; 12(2):97-9. PubMed ID: 16648949
[TBL] [Abstract][Full Text] [Related]
40. In-vitro antimicrobial susceptibility of Neisseria gonorrhoeae in New Zealand.
Green MJ
Br J Vener Dis; 1978 Oct; 54(5):316-21. PubMed ID: 101276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
